Vident Investment Advisory, LLC Dexcom Inc Transaction History

Vident Investment Advisory, LLC

$0
Q3 2023

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$112.47 - $130.98 $61,183 - $71,253	544 Added 18.07%	3,554 $456,000
Q1 2023 May 15, 2023	BUY	$104.0 - $122.92 $31,616 - $37,367	304 Added 11.23%	3,010 $349,000
Q4 2022 Feb 14, 2023	BUY	$84.98 - $122.67 $229,955 - $331,945	2,706 New	2,706 $306,000
Q2 2022 Aug 15, 2022	BUY	$67.99 - $132.89 $144,614 - $282,657	2,127 Added 302.13%	2,831 $213,000
Q1 2022 May 16, 2022	SELL	$94.08 - $130.2 $111,296 - $154,026	-1,183 Reduced 62.69%	704 $366,000
Q4 2021 Feb 14, 2022	SELL	$129.87 - $162.82 $218,051 - $273,374	-1,679 Reduced 47.08%	1,887 $1.01 Million
Q3 2021 Nov 12, 2021	BUY	$106.71 - $143.18 $21,982 - $29,495	206 Added 6.13%	3,566 $1.95 Million
Q2 2021 Aug 13, 2021	SELL	$80.99 - $107.93 $165,057 - $219,961	-2,038 Reduced 37.75%	3,360 $1.44 Million
Q1 2021 May 14, 2021	SELL	$84.79 - $104.74 $7,970 - $9,845	-94 Reduced 1.71%	5,398 $1.94 Million
Q4 2020 Feb 08, 2021	BUY	$78.0 - $104.5 $5,850 - $7,837	75 Added 1.38%	5,492 $2.03 Million
Q3 2020 Nov 12, 2020	SELL	$95.51 - $112.95 $85,576 - $101,203	-896 Reduced 14.19%	5,417 $2.23 Million
Q2 2020 Jul 17, 2020	SELL	$62.68 - $105.34 $46,571 - $78,267	-743 Reduced 10.53%	6,313 $2.56 Million
Q1 2020 May 12, 2020	SELL	$47.79 - $75.63 $2,293 - $3,630	-48 Reduced 0.68%	7,056 $1.9 Million
Q4 2019 Feb 11, 2020	SELL	$36.62 - $57.29 $6,225 - $9,739	-170 Reduced 2.34%	7,104 $1.55 Million
Q3 2019 Nov 13, 2019	BUY	$35.53 - $43.8 $497 - $613	14 Added 0.19%	7,274 $1.09 Million
Q2 2019 Aug 12, 2019	SELL	$27.84 - $38.92 $1,030 - $1,440	-37 Reduced 0.51%	7,260 $1.09 Million
Q1 2019 May 08, 2019	BUY	$28.07 - $38.18 $3,985 - $5,421	142 Added 1.98%	7,297 $869,000
Q4 2018 Feb 14, 2019	SELL	$26.99 - $37.37 $5,424 - $7,511	-201 Reduced 2.73%	7,155 $857,000
Q3 2018 Nov 14, 2018	SELL	$23.35 - $36.72 $16,461 - $25,887	-705 Reduced 8.75%	7,356 $1.05 Million
Q2 2018 Aug 14, 2018	BUY	$17.54 - $25.22 $141,389 - $203,298	8,061 New	8,061 $765,000

Others Institutions Holding DXCM

# of Institutions

1,014

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vident Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vident Investment Advisory, LLC with notifications on news.

Account